The greatest increase in the plasma follistatin level was observed in the ovarian and peritoneal forms in patients with deep infiltrating endometriosis (DIE) as well as in healthy controls, which excludes its use as a marker of endometriosis [52]. This evidence concerns the gene FST and endometriosis.